Candice L Garwood

Summary

Affiliation: Wayne State University
Country: USA

Publications

  1. ncbi Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 31:1208-20. 2011
  2. ncbi Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene
    Candice L Garwood
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan 48201, and the Department of Family Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA
    Pharmacotherapy 26:881-5. 2006
  3. ncbi Is there a role for fondaparinux in perioperative bridging?
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA
    Am J Health Syst Pharm 68:36-42. 2011
  4. ncbi Warfarin maintenance dose in older patients: higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestry
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Blood Cells Mol Dis 45:93-7. 2010
  5. ncbi Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 42:523-32. 2008
  6. ncbi Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 28:20-6. 2008
  7. ncbi Emerging pharmacotherapies for smoking cessation
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Am J Health Syst Pharm 64:1693-8. 2007
  8. ncbi Bridging for an isolated subtherapeutic INR: an evaluation of clinical practice patterns, outcomes, and costs from an anticoagulation clinic
    Jamie M Hwang
    Department of Pharmacy, Harper University Hospital, 3990 John R Street, Detroit, MI, USA
    J Thromb Thrombolysis 33:28-37. 2012
  9. ncbi Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic
    Megan E Kleinow
    Harper University Hospital, Detroit Medical Center, and Department of Emergency Medicine, Wayne State University, 421 E Canfield, Detroit, MI 48201 USA
    J Manag Care Pharm 17:523-30. 2011
  10. ncbi Transportation cost of anticoagulation clinic visits in an urban setting
    Jamie M Hwang
    Department of Pharmacy, Harper University Hospital, Detroit, Michigan, USA
    J Manag Care Pharm 17:635-40. 2011

Collaborators

Detail Information

Publications16

  1. ncbi Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 31:1208-20. 2011
    ..Patients taking dabigatran are unlikely to require bridge therapy because of a predictable anticoagulant effect and rapid onset of action. However, evidence for optimal perioperative management of dabigatran is needed...
  2. ncbi Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene
    Candice L Garwood
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan 48201, and the Department of Family Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA
    Pharmacotherapy 26:881-5. 2006
    ..Further investigation of this potential interaction is warranted. Until then, clinicians should be alert to the potential for an interaction between raloxifene and levothyroxine...
  3. ncbi Is there a role for fondaparinux in perioperative bridging?
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA
    Am J Health Syst Pharm 68:36-42. 2011
    ..A possible role for fondaparinux as a bridging agent in the perioperative setting is explored...
  4. ncbi Warfarin maintenance dose in older patients: higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestry
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Blood Cells Mol Dis 45:93-7. 2010
    ....
  5. ncbi Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 42:523-32. 2008
    ..To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls...
  6. ncbi Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, USA
    Pharmacotherapy 28:20-6. 2008
    ..To determine if transitioning patients from a pharmacist- managed anticoagulation clinic after stabilization of warfarin therapy to physician-managed care alters the quality of anticoagulation care...
  7. ncbi Emerging pharmacotherapies for smoking cessation
    Candice L Garwood
    Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    Am J Health Syst Pharm 64:1693-8. 2007
    ..The neurobiology of tobacco dependence and the efficacy and safety of emerging pharmacotherapies for smoking cessation are reviewed...
  8. ncbi Bridging for an isolated subtherapeutic INR: an evaluation of clinical practice patterns, outcomes, and costs from an anticoagulation clinic
    Jamie M Hwang
    Department of Pharmacy, Harper University Hospital, 3990 John R Street, Detroit, MI, USA
    J Thromb Thrombolysis 33:28-37. 2012
    ..13) and its components, direct medical ($951.32), transportation ($2.73) and productivity cost ($13.08). It is unclear if bridging for an isolated subtherapeutic INR reduces thrombosis risk, but it is associated with higher costs...
  9. ncbi Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic
    Megan E Kleinow
    Harper University Hospital, Detroit Medical Center, and Department of Emergency Medicine, Wayne State University, 421 E Canfield, Detroit, MI 48201 USA
    J Manag Care Pharm 17:523-30. 2011
    ..Specifically, we anticipated that more dose manipulations (both dose changes and transient dose adjustments) and shorter times between scheduled clinic visits would be required for anticoagulation patients with CKD...
  10. ncbi Transportation cost of anticoagulation clinic visits in an urban setting
    Jamie M Hwang
    Department of Pharmacy, Harper University Hospital, Detroit, Michigan, USA
    J Manag Care Pharm 17:635-40. 2011
    ..International studies have evaluated transportation cost and associated time related to anticoagulation clinic visits. To our knowledge, no studies have evaluated the cost of transportation to such clinic visits in the United States...
  11. ncbi The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy
    Hanan S Khreizat
    Department of Pharmacy, Harper University Hospital, Detroit Medical Center, Detroit, MI, USA
    Drugs Aging 29:307-17. 2012
    ..Nevertheless, there are limited data on warfarin use in such patients; therefore, we investigated anticoagulation stability in patients with and without CI...
  12. ncbi Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly
    Helen D Berlie
    Department of Pharmacy Practice, Wayne State University, Detroit, MI 48201, USA
    Ann Pharmacother 44:712-7. 2010
    ..To review literature regarding the effect of diabetes medications as a contributing risk for falls and fall-related morbidity in elderly patients with type 2 diabetes...
  13. ncbi Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia
    Tia L Corbett
    Department of Pharmacy, Sinai Grace Hospital, Detroit Medical Center, 6071 W Outer Drive, Detroit, MI 48235, USA
    J Thromb Thrombolysis 30:375-7. 2010
    ..However, further clinical investigations are warranted to confirm both the safety and efficacy of this agent in the mechanical heart valve population...
  14. ncbi An objective structured clinical examination to assess problem-based learning
    Francine D Salinitri
    Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201 2427, USA
    Am J Pharm Educ 76:44. 2012
    ....
  15. ncbi An innovative elective course in anticoagulation management
    Candice L Garwood
    Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, USA
    Am J Pharm Educ 74:187. 2010
    ..To develop and implement an elective pharmacy course in anticoagulation management and assess student learning...
  16. ncbi Varenicline: the newest agent for smoking cessation
    Lisa A Potts
    Department of Pharmacy, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Health Syst Pharm 64:1381-4. 2007
    ..The pharmacology, pharmacokinetics, clinical efficacy, safety, dosage and administration, and place in therapy of varenicline are reviewed...